DNA methylation is associated with inhaled corticosteroid response in persistent childhood asthmatics

Background Response to inhaled corticosteroids is highly variable, and the association between DNA methylation and treatment response is not known. Objective To examine the association between peripheral blood DNA methylation and inhaled corticosteroid response in children with persistent asthma. Me...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental allergy Vol. 49; no. 9; pp. 1225 - 1234
Main Authors Wang, Alberta L., Gruzieva, Olena, Qiu, Weiliang, Kebede Merid, Simon, Celedón, Juan C., Raby, Benjamin A., Söderhäll, Cilla, DeMeo, Dawn L., Weiss, Scott T., Melén, Erik, Tantisira, Kelan G.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.09.2019
Subjects
Online AccessGet full text
ISSN0954-7894
1365-2222
1365-2222
DOI10.1111/cea.13447

Cover

More Information
Summary:Background Response to inhaled corticosteroids is highly variable, and the association between DNA methylation and treatment response is not known. Objective To examine the association between peripheral blood DNA methylation and inhaled corticosteroid response in children with persistent asthma. Methods Epigenome‐wide DNA methylation was analysed in individuals on inhaled corticosteroids in three independent and ethnically diverse cohorts—Childhood Asthma Management Program (CAMP); Children, Allergy, Milieu, Stockholm, Epidemiology (BAMSE); and Genetic Epidemiology of Asthma in Costa Rica Study (GACRS). Treatment response was evaluated using two definitions, the absence of emergency department visits and/or hospitalizations and the absence oral corticosteroid use while on inhaled corticosteroid therapy. CpG sites meeting nominal significance (P < 0.05) for each outcome were combined in a three‐cohort meta‐analysis with adjustment for multiple testing. DNA methylation was correlated with gene expression using Pearson and partial correlations. Results In 154 subjects from CAMP, 72 from BAMSE, and 168 from GACRS, relative hypomethylation of cg00066816 (171 bases upstream of IL12B) was associated with the absence of emergency department visits and/or hospitalizations (Q = 0.03) in all cohorts and lower IL12B expression (ρ = 0.34, P = 0.01) in BAMSE. Relative hypermethylation of cg04256470 (688 bases upstream of CORT) was associated with the absence of oral corticosteroid use (Q = 0.04) in all cohorts and higher CORT expression (ρ = 0.20, P = 0.045) in CAMP. Conclusion and Clinical Relevance Differential DNA methylation of IL12B and CORT are associated with inhaled corticosteroid treatment response in persistent childhood asthmatics. Pharmaco‐methylation can identify novel markers of treatment sensitivity in asthma.
Bibliography:Funding information
NIH T32 AI007306, T32 HL007427, RC2 HL101543, R01 HL127332, R01 HL129935, U01 HL65899, P01 HL132825. BAMSE: The Swedish Heart‐Lung Foundation, The Swedish Research Council, Stockholm County Council (ALF), MeDALL (Mechanisms of the Development of ALLergy; European Union grant agreement No. 261357) and the Swedish foundation for strategic research (SSF) (RBc08‐0027).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0954-7894
1365-2222
1365-2222
DOI:10.1111/cea.13447